mmol/l, n = 22), vitamin D deficiency (n = 3), thyroidectomy (n = 3), the newborn (n = 10), and a variety of other disorders including liver failure (n = 23); (b) hypercalcaemia (Ca > 3-0 mmoll1) associated with primary hyperparathyroidism (n= ), bone secondaries (n = 6), and a variety of other disorders (n = 10); and (c) calcium concentrations that were normal (2-15-2-70 mmol/l) and included patients who had thyrotoxicosis (n = 10), hypothyroidism (n = 6), liver disease (n = 6), hypophosphataemia (phosphate < 0 6 mmol/l, n = 8), and other miscellaneous disorders (n = 11). Control samples (n = 18) were obtained from laboratory staff.
In common with most steroids, vitamin D (cholecalciferol) and its metabolites circulate in human plasma bound to protein. Recently, it has become apparent that this vitamin D binding protein is identical with group-specific component protein, Gc-globulin.1 Although this CX2-globulin was first detected over 20 years ago,2 most studies on it have centred on its value as a genetic marker since two common codominant autosomal alleles, Gcd and Gc2, are found in all populations. With the assignment of a function to the products of these alleles there is an increased interest in the relationship between their properties and concentrations and disorders of calcium metabolism. There appears to be little difference in the vitamin D binding properties of plasma from healthy individuals with the three normal phenotypes Gd-1, Gc-globulin is synthesised in the liver,4 and plasma concentrations generally fall to a moderate extent in chronic liver disease. (urea > 20 mmol/l, n = 22), vitamin D deficiency (n = 3), thyroidectomy (n = 3), the newborn (n = 10), and a variety of other disorders including liver failure (n = 23); (b) hypercalcaemia (Ca > 3-0 mmoll1) associated with primary hyperparathyroidism (n= ), bone secondaries (n = 6), and a variety of other disorders (n = 10); and (c) calcium concentrations that were normal (2-15-2-70 mmol/l) and included patients who had thyrotoxicosis (n = 10), hypothyroidism (n = 6), liver disease (n = 6), hypophosphataemia (phosphate < 0 6 mmol/l, n = 8), and other miscellaneous disorders (n = 11). Control samples (n = 18) were obtained from laboratory staff. 25-hydroxy(26(27)-methyl-3H) cholecalciferol (Radiochemical Centre, Amersham, specific activity 9-0-11 8 Ci/mmol) also dissolved in ethanol (0-04 ml containing 1 8-2 5 pmol) was pipetted out into the tubes. To each assay tube was added 0 4 ml of plasma diluted 1: 800 with phosphate buffer (0 05 mol/l containing gelatin, 200 mg/l, pH 7 6) and the solutions were incubated for 2 hours at 4°C. Non-specific binding was obtained by incubating buffer instead of diluted plasma. At the end of the incubation period 0-2 ml of dextrancharcoal (1-25 g Norit GSX (Hopkin and Williams Ltd) and 0-125 g dextran (Koch-Light, MW 60 000-90 000) in 100 ml H20) was added, and after a further 20 minutes at 40C the tubes were centrifuged; 0-4 ml of the supernatant was removed, and the radioactivity was counted in a modified Bray's scintillation solution.6 The results were analysed as Scatchard plots7 and the association constants (Ka) and binding capacities (Cap) were calculated.8
PROTEIN MEASUREMENTS
Specific proteins were measured in some of the samples used in the screening procedure and also in a few selected patients during the course of their illness. Transferrin, caeruloplasmin, and Gc-globulin were measured using M-Partigen immunodiffusion plates (Hoechst Pharmaceuticals) containing the appropriate antiserum. Albumin was measured by a bromocresol green dye-binding method (Technicon Method AAII No. 30 ).
Results
The The 25(OH)D3 binding capacity should be a measure of the concentration of Gc-globulin in plasma. That this was so was tested by measuring Gc-globulin concentrations by radial immunodiffusion in plasma samples selected so as to give a wide range of binding capacities. Figure 1 shows the relationship between these two independent estimates of vitamin D binding globulin. A highly significant correlation was found (r = 078, P < 0001) (y = 14 7x -0-34).
During the course of these screening procedures it became obvious that there was considerable variation in the vitamin D binding capacity of samples from different patients. Figure 2 shows that, although there was a significant correlation between binding capacity and albumin (r = 0-53, P < 0-001), there was in the samples assayed roughly a 10-fold variation in the former compared with only a twofold variation in the latter. This implies that the concentration of Gc-globulin in human plasma is rather more variable than that of albumin.
These observations, therefore, prompted us to examine the temporal relationships between Gcglobulin and some other proteins during the course 25-hydroxy vitamin D association constants (Ka) and plasma binding capacities (Cap) A 41-year-old man had three parathyroid adenomata removed. His postoperative course was uneventful until the last blood sample taken on day 15. In this patient transferrin and albumin concentrations fell postoperatively and had not quite regained the preoperative concentrations by day 15. Caeruloplasmin concentration rose from day 3 to day 8 and was still elevated after 15 days. Gc-globulin paralleled the changes in caeruloplasmin from day 1 to day 6 but subsequently its concentration fell and by day 15 was only 10% above the day 0 value. Thus, in this patient, the Gc-globulin is acting like an 'acute phase reactant' but with a response that is less Albumin (gIl) Fig. 2 Relationship between plasma 25(OH)D3 binding capacity (ILmol/l) and albumin (gil).
sustained than the more typical response of caeruloplasmin. CASE 
2
A 67-year-old man was admitted with a suspected and subsequently confirmed myocardial infarction. There was no extension of the infarct; the patient improved rapidly and was eventually discharged 13 protein measurements but nevertheless it is quite clear that the Gc-globulin changed in a markedly different fashion from the other three proteins. The concentrations of all four proteins were depressed in the first few days, but the Gc-globulin fell to the lowest level at 40 % of that seen on admission. From day 4 onwards there was a slow rise in transferrin, caeruloplasmin, and albumin, the transferrin and caeruloplasmin concentrations by day 9 being close to those found on admission, though the albumin remained depressed for the next three weeks. However, in contrast, there was a remarkable 'overshoot' in the Gc-globulin concentration, and between day 2 and day 10 it changed from 40% to 150% of the admission value. It then remained at this high level for the next two weeks. The patient was not taking
The object of the present study was to try to get further information on the role, if any, that Gcglobulin might play in the pathogenesis of disorders of mineral metabolism. Previous studies have shown that Gc-globulin concentrations are depressed in chronic liver disease5 but that the concentrations remain within the normal range in a variety of situations, including vitamin D deficiency, vitamin D therapy, sarcoidosis, osteoporosis, and thyrotoxicosis.9 10 In common with many other proteins, the concentrations are increased by pregnancy and oestrogen preparations. Increases have also been reported in haemochromatosis" and chronic active hepatitis. '2 The only function so far ascribed to Gc-globulin is that of transporting vitamin D metabolites. However, at normal physiological concentrations of 25(OH)D3 (25-100 nmol/l), the binding capacity of human plasma is only about 3 % saturated. Thus it would appear that only a major decrease in circulating Gc-globulin would be sufficient to interfere with vitamin D transport. Previous reports indicate that the reductions are not severe enough to account for the disturbances in bone metabolism that occur in chronic liver disease.5
In our present survey three out of the 123 patients studied had plasma Gc-globulin concentrations less than 0-10 g/l (reference range 0-25-0-35 g/l). By chance, results for transferrin and caeruloplasmin concentrations were also available on these patients and were found to be normal in two 
